[go: up one dir, main page]

SG52658A1 - Tryptase inhibitor - Google Patents

Tryptase inhibitor

Info

Publication number
SG52658A1
SG52658A1 SG1996007450A SG1996007450A SG52658A1 SG 52658 A1 SG52658 A1 SG 52658A1 SG 1996007450 A SG1996007450 A SG 1996007450A SG 1996007450 A SG1996007450 A SG 1996007450A SG 52658 A1 SG52658 A1 SG 52658A1
Authority
SG
Singapore
Prior art keywords
pct
novel
sec
date
vectors
Prior art date
Application number
SG1996007450A
Other languages
English (en)
Inventor
Christian P Sommerhoff
Hans Fritz
Original Assignee
Ucp Gen Pharma Ag
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ucp Gen Pharma Ag, Novartis Ag filed Critical Ucp Gen Pharma Ag
Publication of SG52658A1 publication Critical patent/SG52658A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81Protease inhibitors
    • C07K14/8107Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811Serine protease (E.C. 3.4.21) inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Mycology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Pulmonology (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
SG1996007450A 1993-07-26 1994-07-25 Tryptase inhibitor SG52658A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP93111930 1993-07-26

Publications (1)

Publication Number Publication Date
SG52658A1 true SG52658A1 (en) 1998-09-28

Family

ID=8213112

Family Applications (1)

Application Number Title Priority Date Filing Date
SG1996007450A SG52658A1 (en) 1993-07-26 1994-07-25 Tryptase inhibitor

Country Status (13)

Country Link
US (1) US5972698A (no)
EP (1) EP0714408B1 (no)
JP (1) JPH09500532A (no)
AT (1) ATE245660T1 (no)
AU (1) AU694444B2 (no)
CA (1) CA2164221A1 (no)
DE (1) DE69432975T2 (no)
FI (1) FI960333L (no)
NO (1) NO960325L (no)
NZ (1) NZ271635A (no)
SG (1) SG52658A1 (no)
TW (1) TW492975B (no)
WO (1) WO1995003333A2 (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000500156A (ja) * 1995-11-13 2000-01-11 フールマン,ヘラルド ヒルから得られる抗ウイルス性単離物
WO1997022626A1 (en) * 1995-12-15 1997-06-26 Novartis Ag Ldti crystals
GB9916913D0 (en) * 1999-07-19 1999-09-22 Natural Enviromental Research Inhibitor proteins
CA2580881A1 (en) 2004-09-21 2006-03-30 Nascacell Technologies Ag Use of microproteins as tryptase inhibitors
CN108017693A (zh) * 2017-12-14 2018-05-11 中国科学院昆明动物研究所 一种抗凝肽syap-1及其突变体和包括抗凝肽和/或突变体的抑制剂

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU560584B2 (en) * 1983-07-28 1987-04-09 Bayer Aktiengesellschaft Homologues of aprotinin
US4666829A (en) * 1985-05-15 1987-05-19 University Of California Polypeptide marker for Alzheimer's disease and its use for diagnosis
JPS6351335A (ja) * 1986-08-20 1988-03-04 Fuji Oil Co Ltd 肥満細胞脱顆粒抑制剤
US5187153A (en) * 1986-11-17 1993-02-16 Scios Nova Inc. Methods of treatment using Alzheimer's amyloid polypeptide derivatives
US4912206A (en) * 1987-02-26 1990-03-27 The United States Of America As Represented By The Department Of Health And Human Services CDNA clone encoding brain amyloid of alzheimer's disease
JPH01110697A (ja) * 1987-07-03 1989-04-27 Taisho Pharmaceut Co Ltd 新規プロテアーゼ阻害物質
DE58907373D1 (de) * 1988-03-07 1994-05-11 Ciba Geigy Modifizierte Proteine.
NZ231658A (en) * 1988-12-12 1992-05-26 Fmc Corp Inhibitors of protoporphyrinogen oxidase and compositions for killing tumour cells
KR920700287A (ko) * 1989-02-22 1992-02-19 사와무라 하루오 신규의 프로테아제 억제물질 및 그것의 제조방법
IL98405A0 (en) * 1990-06-11 1992-07-15 Fmc Corp Pharmaceutical compositions containing enzyme inhibiting agents

Also Published As

Publication number Publication date
AU694444B2 (en) 1998-07-23
FI960333A7 (fi) 1996-01-24
FI960333A0 (fi) 1996-01-24
AU7532494A (en) 1995-02-20
CA2164221A1 (en) 1995-02-02
EP0714408B1 (en) 2003-07-23
EP0714408A1 (en) 1996-06-05
US5972698A (en) 1999-10-26
NZ271635A (en) 1998-04-27
TW492975B (en) 2002-07-01
ATE245660T1 (de) 2003-08-15
NO960325D0 (no) 1996-01-26
JPH09500532A (ja) 1997-01-21
WO1995003333A3 (en) 1995-03-23
DE69432975T2 (de) 2004-05-06
NO960325L (no) 1996-01-26
FI960333L (fi) 1996-01-24
WO1995003333A2 (en) 1995-02-02
DE69432975D1 (en) 2003-08-28

Similar Documents

Publication Publication Date Title
GR3027660T3 (en) Recombinant viruses and their use in gene therapy
DE69531457D1 (en) Sulfonamide
TW279166B (no)
GR3033846T3 (en) Imidazopyridines and their use in treating gastrointestinal diseases.
ZA963593B (en) IL-6 activity inhibitor
DE69412856D1 (de) Polyolzusammensetzungen sowie ihre verwendung zur herstellung von hochelastischen polyurethanschaumstoffen
PT716611E (pt) Metodo para reduzir a lesao do miocardio durante um enfarte do miocardio agudo
DE69432975D1 (en) Tryptase hemmer
HUT70215A (en) Thrombin inhibitors
ZA961419B (en) Human DNase I variants.
HU9601298D0 (en) Endothelin-converting enzyme
NO961357D0 (no) Nye terapeutisk aktive peptidforbindelser i blodkoagulasjonskaskaden, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem
MX9706429A (es) Variantes de dnasa i humana.